A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally

NCT05098938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2020

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Herpes Labialis

Interventions

DRUG: Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773
DRUG: Placebo

Sponsor

Bayer